Core Insights - Glucotrack, Inc. is participating in the FORGETDIABETES initiative to develop a long-term automated insulin delivery system for optimal glucose control without patient intervention [1][2] - The FORGETDIABETES initiative is funded by the European Union's Horizon 2020 program, which has a budget of €75 billion for various research and innovation projects [2] - The initiative aims to create a bionic pancreas that alleviates the daily management burden of type 1 diabetes, transforming it into a more manageable lifestyle condition [3][4] Company Overview - Glucotrack focuses on designing, developing, and commercializing novel technologies for diabetes management, including a Continuous Blood Glucose Monitor (CBGM) [6][7] - The CBGM is a long-term implantable system with a sensor longevity of 3 years, requiring minimal calibration and no on-body wearable component [7] Initiative Details - The FORGETDIABETES initiative includes various participants, such as the University of Padova, BioRobotics Institute, and several health institutions across Europe [4] - The initiative aims to integrate Glucotrack's CBGM into automated insulin delivery systems, enhancing diabetes management [4]
Glucotrack to Participate in FORGETDIABETES, a Prominent European Research Initiative to Develop a Bionic Pancreas